Biophytis (EPA:ALBPS)

PRESS RELEASE

published on 06/07/2024 at 07:39, 1 year 7 months ago

Combined General Meeting of June 24, 2024
Biophytis to hold Combined General Meeting (CGM) on June 24, 2024 at Sorbonne Université. Shareholders urged to vote in advance. Company specializes in age-related disease therapeutics

Shareholders Biophytis Therapeutics Combined General Meeting Age-related Diseases
BRIEF

published on 05/14/2024 at 07:05, 1 year 8 months ago

Biophytis Unveils Phase 2 OBA Clinical Study Design in Obesity

Biophytis Obesity Treatment Clinical Trial BIO101 OBA Clinical Study
PRESS RELEASE

published on 05/14/2024 at 07:00, 1 year 8 months ago

Biophytis announces the design of its phase 2 OBA clinical study in obesity
Biophytis announces the design of its phase 2 OBA clinical study in obesity with BIO101 (20-hydroxyecdysone), targeting muscle preservation in patients with obesity undergoing weight loss treatment with GLP-1 RAs

Biophytis BIO101 Muscle Preservation Obesity Phase 2 OBA Clinical Study
REGULATED PRESS RELEASE

published on 05/14/2024 at 07:00, 1 year 8 months ago

Biophytis announces the design of its phase 2 OBA clinical study in obesity
Biophytis announces the design of its phase 2 OBA clinical study in obesity with BIO101 (20-hydroxyecdysone), aiming to test efficacy and safety for muscle function in obese patients. Study to start mid-2024 with results expected in 2025

Biophytis BIO101 Obesity Phase 2 OBA Clinical Study Muscle Function
BRIEF

published on 04/29/2024 at 14:44, 1 year 9 months ago

Biophytis announces the deployment of its partnership strategy in the obesity sector

Strategic Partnerships Biophytis Pharmaceutical BIO101 Obesity
PRESS RELEASE

published on 04/29/2024 at 14:39, 1 year 9 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces the implementation of a dedicated partnership strategy in obesity, aiming to collaborate with global pharmaceutical companies for drug development and commercialization. CEO Stanislas Veillet emphasizes the importance of addressing the obesity medical challenge through partnerships

Biophytis Drug Development Obesity Partnership Strategy Pharmaceutical Companies
BRIEF

published on 04/29/2024 at 07:05, 1 year 9 months ago

Biophytis Advances Partnership Strategy in Obesity Sector

Biophytis Obesity Treatment Healthcare Innovation Pharmaceutical Partnerships BIO101
REGULATED PRESS RELEASE

published on 04/29/2024 at 07:00, 1 year 9 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces partnership strategy for obesity, aiming to license out drug candidate BI0101 to global pharma companies for development, launch, and commercialization. CEO stresses importance of partnering for medical innovation

Biophytis Medical Innovation Obesity Partnership Strategy Drug Candidate
BRIEF

published on 04/24/2024 at 23:05, 1 year 9 months ago

Biophytis Transfers ADSs to OTC Market Following Nasdaq Delisting

Biophytis Euronext Growth Nasdaq Delisting OTC Market Stockholders' Equity
PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 9 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces transfer of ADSs to OTC market, resulting in cost savings. ADSs to trade on OTC Pink, while applying for OTCQB. Company remains listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs

Published on 01/31/2026 at 03:15, 5 hours 39 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 6 hours 34 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 7 hours 14 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 8 hours 54 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 9 hours 54 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 02:45, 6 hours 9 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 10 hours 54 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 12 hours 44 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 12 hours 44 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 12 hours 47 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 17:45, 15 hours 9 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 1 day ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 14 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 15 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 15 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News